Importantly,TDI-11055 inhibited disease progression in xenograft models of MLL-rearrangedand NPM1-mutated AML. To improve cellularactivity and metabolic stability, other chemotypes such as piperazine-ureaderivatives were explored. The gene discussed is KMT2A; the disease is acute myeloid leukemia.